Benefits of Brentuximab Vedotin & Chemotherapy Combination for Advanced Stage Hodgkin Lymphoma
June 5th 2018Radhakrishnan Ramchandren MD, highlights the recent US Food and Drug Administration’s (FDA) approval and advantages of ADCETRIS (brentuximab vedotin) in combination with chemotherapy for advanced stage, classic Hodgkin lymphoma.
Read More